Laxifolone A suppresses LPS/IFN-γ-induced NO synthesis by attenuating NF-κB translocation: Role of NF-κB p105 level

Planta Medica

Volumn 71, Issue 6, 2005, Pages 514-519

  Ko, Han Chieh ^a   Kuo, Yao Haur ^a   Wei, Bai Luh ^b   Chiou, Wen Fei ^a,b  

^a NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^b NATIONAL TAITUNG UNIVERSITY   (Taiwan)

Author keywords

INOS; l B; Laxifolone A; NF B; NF B p105; NO

Indexed keywords

GAMMA INTERFERON; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LAXIFOLONE A; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRITE; PROTEIN P105; SYNAPTOTAGMIN; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; EUONYMUS; GENETIC TRANSCRIPTION; IC 50; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; EUONYMUS; INHIBITORY CONCENTRATION 50; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHYTOTHERAPY; PLANT EXTRACTS; PLANT STEMS; RNA, MESSENGER; TRITERPENES;

EUONYMUS;

EID: 21344433482     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-864151     Document Type: Article

References (27)

1. Fox SB, Gatter KC, Bicknell R, Going JJ, Stanton P, Cooke TG, Harris AL. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res 1993; 53: 4161-3
2. Verheul HM, Bom JB, Hoekman K, Pinedo HM. Inhibition of tumor angiogenesis as a cancer treatment. Nederlands Tijdschrift voor Geneeskunde 1999; 143: 1549-55
3. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995; 92: 4392-6
4. Jenkins DC, Charles IG, Baylis SA, Lelchuk R, Radomski MW, Moncada S. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer 1994; 70: 847-9
5. Perkins ND. NF-κB tumor promoter or suppressor. Trend Cell Biol 2004; 14: 64-9
6. Bharti AC, Aggarwal BB. Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem Pharmacol 2002; 64: 883-8
7. Baeuerle PA, Baltimore D. I kappa B: A specific inhibitor of the NF-kappa B transcription factor. Science 1988; 242: 540-6
8. Li CC, Dai RM, Longo DL. Inactivation of NF-kappa B inhibitor I kappa Bα: Ubiquitin-dependent proteolysis and its degradation product. Biochem Biophys Res Commun 1995; 215: 292-301
9. Fan CM, Maniatis T. Generation of p50 subunit of NF-kappa B by processing of p105 through ATP-dependent pathway. Nature 1991; 354: 395-8
10. Liou HC, Nolan GP, Ghosh S, Fujita T, Baltimore D. The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50. EMBO J 1992; 11: 3003-9
11. Duan H, Takaishi Y, Imakura Y, Jia Y, Li D, Cosentino LM, Lee KH. Sesquiterpene alkaloids from Tripterygium hypoglaucum and Tripterygium wiifordii: a new class of potent anti-HIV agents. J Nat Prod 2000; 63: 357-61
12. Duan H, Takaishi Y, Momota H, Ohmoto Y, Taki T, Jia Y, Li D. Immunosuppressive sesquiterpene alkaloids from Tripterygium wiifordii. J Nat Prod 2001; 64: 582-7
13. Takaishi Y, Ohshima S, Nakano K, Tomimatsu T, Tokuda H, Nishino H, Iwashima A. Structures of sesquiterpene polyol esters from Celastrus stephanotiifolius with potential tumor-promotion inhibitory activity. J Nat Prod 1993; 56: 815-24
14. Cheng CY, Huang PH. Flora Reipublicae Popularis Sinicae. Beijing: Science Press, 1999; Vol. 45, No. 3
15. Kuo YH, Huang HC, Chiou WF, Shi LS, Wu TS, Wu YC. A novel NO-production-inhibiting triterpene and cytotoxicity of known alkaloids from Euonymus laxiflorus. J Nat Prod 2003; 66: 554-7
16. Chiou WF, Chen CF, Lin JJ. Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells by andrographolide. Br J Pharmacol 2000; 129: 1553-60
17. Hsu SM, Chen YC, Jiang MC. 17β-Estradiol inhibits tumor necrosis factor-α-induced nuclear factor-κB activation by increasing nuclear factor-κB p105 level in MCF-7 breast cancer cells. Biochem Biophy Res Commun 2000; 279: 47-52
18. Spivey AC, Weston M, Woodhead S. Celastraceae sesquiterpenoids: biological activity and synthesis. Chem Soc Rev 2002; 31: 43-59
19. Gonzalez AG, Tincusi BM, Bazzocchi IL, Tokuda H, Nishino H, Konoshima T, Jimenez IA, Ravelo AG. Anti-tumor promoting effects of sesquiterpenes from Maytenus cuzcoina (Celastraceae). Bioorg Med Chem 2000; 8: 1773-8
20. Thomsen LL, Miles DW. Role of nitric oxide in tumor progression: lessons from human tumours. Cancer Metastasis Rev 1998; 17: 107-18
21. Ziehe M. Role of nitric oxide in the angiogenesis of a vascular tissue. Osteoarthritis Cartilage 1999; 7: 403-5
22. Wall ME, Wani MC. Camptothecin and taxol: from discovery to clinic. J Ethnopharmacol 1996; 51: 239-54
23. Chiou WF, Chou CJ, Chen CF. Camptothecin suppresses nitric oxide biosynthesis in RAW264.7 macrophages. Life Sci 2001; 69: 625-35
24. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269: 4705-8
25. Thanos D, Maniatis T. NF-kappa B: a lesson in family values. Cell 1995; 80: 529-32
26. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappa B. J Clin Invest 2001; 107: 241-6
27. Naumann M, Scheidereit C. Activation of NF-kappa B in vivo is regulated by multiple phosphorylations. EMBO J 1994; 13: 4597-607